Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Milad Ashrafizadeh, Md Shahinozzaman, Sima Orouei, et al.
Current Cancer Drug Targets (2021) Vol. 21, Iss. 8, pp. 640-665
Closed Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

NF‐κB as a regulator of cancer metastasis and therapy response: A focus on epithelial–mesenchymal transition
Sepideh Mirzaei, Sam Saghari, Farzaneh Bassiri, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 7, pp. 2770-2795
Closed Access | Times Cited: 151
EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113774-113774
Open Access | Times Cited: 95
Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: Promises and Challenges
Mahshid Deldar Abad Paskeh, Fatemeh Ghadyani, Mehrdad Hashemi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106553-106553
Open Access | Times Cited: 83
Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling
Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112963-112963
Open Access | Times Cited: 81
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 435-452
Closed Access | Times Cited: 44
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
Biological functions and molecular interactions of Wnt/β-catenin in breast cancer: Revisiting signaling networks
Mehrdad Hashemi, Sahar Hasani, Shima Hajimazdarany, et al.
International Journal of Biological Macromolecules (2023) Vol. 232, pp. 123377-123377
Closed Access | Times Cited: 25
STAT3 as a newly emerging target in colorectal cancer therapy: Tumorigenesis, therapy response, and pharmacological/nanoplatform strategies
Mehrdad Hashemi, Sahar Abbaszadeh, Mohsen Rashidi, et al.
Environmental Research (2023) Vol. 233, pp. 116458-116458
Closed Access | Times Cited: 23
Malignant function of nuclear factor-kappaB axis in prostate cancer: Molecular interactions and regulation by non-coding RNAs
Reyadh R. Al‐Rashidi, Sara Abdalrazzaq M. Noraldeen, Ali Kamil Kareem, et al.
Pharmacological Research (2023) Vol. 194, pp. 106775-106775
Open Access | Times Cited: 22
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 42
Long non-coding RNA/epithelial-mesenchymal transition axis in human cancers: Tumorigenesis, chemoresistance, and radioresistance
Mehrdad Hashemi, Shima Hajimazdarany, Chakrabhavi Dhananjaya Mohan, et al.
Pharmacological Research (2022) Vol. 186, pp. 106535-106535
Closed Access | Times Cited: 29
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance
Mehrdad Hashemi, Eisa Sabouni, Parham Rahmanian, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 20
Multifaceted role of NF-κB in hepatocellular carcinoma therapy: Molecular landscape, therapeutic compounds and nanomaterial approaches
Reena Gupta, Mustafa M. Kadhim, Abduladheem Turki Jalil, et al.
Environmental Research (2023) Vol. 228, pp. 115767-115767
Closed Access | Times Cited: 17
Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu, Yang Liu, Xin Peng, et al.
Cancer Letters (2024) Vol. 588, pp. 216738-216738
Closed Access | Times Cited: 7
CircRNAs and lung cancer: Insight into their roles in metastasis
Jiaoyang Ning, Yixin Luo, Liu Chen, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115260-115260
Open Access | Times Cited: 14
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
New insight in urological cancer therapy: From epithelial-mesenchymal transition (EMT) to application of nano-biomaterials
Peng He, Qiang Dai, Xiaojun Wu
Environmental Research (2023) Vol. 229, pp. 115672-115672
Closed Access | Times Cited: 12
Role of lncRNA PVT1 in the progression of urological cancers: Novel insights into signaling pathways and clinical opportunities
Mehrdad Hashemi, Hamidreza Gholamrezaei, Faezeh Ziyaei, et al.
Cellular Signalling (2025), pp. 111736-111736
Closed Access
Autophagy as a self-digestion signal in human cancers: Regulation by microRNAs in affecting carcinogenesis and therapy response
Mustafa M. Kadhim, Andrés Alexis Ramírez‐Coronel, Abduladheem Turki Jalil, et al.
Pharmacological Research (2023) Vol. 189, pp. 106695-106695
Open Access | Times Cited: 9
Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control
Afshin Taheriazam, Seyedeh Delaram Bayanzadeh, Melika Heydari Farahani, et al.
European Journal of Pharmacology (2023) Vol. 951, pp. 175781-175781
Closed Access | Times Cited: 8
Unveiling the Power of Flavonoids: A Dynamic Exploration of Their Impact on Cancer through Matrix Metalloproteinases Regulation
Peramaiyan Rajendran
Biomedicine (2024) Vol. 14, Iss. 2
Open Access | Times Cited: 2
CEACAM1 increased the lymphangiogenesis through miR-423-5p and NF- kB in Non-Small Cell Lung Cancer
Jie Yu, Wen-Ke Cai, Tao Zhou, et al.
Biochemistry and Biophysics Reports (2024) Vol. 40, pp. 101833-101833
Open Access | Times Cited: 2
Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi, et al.
European Journal of Pharmacology (2022) Vol. 932, pp. 175212-175212
Closed Access | Times Cited: 11
miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154906-154906
Closed Access | Times Cited: 6
HEY1-mediated cisplatin resistance in lung adenocarcinoma via epithelial–mesenchymal transition
Jin Gao, Yadong Li, Xiaoteng Zou, et al.
Medical Oncology (2022) Vol. 40, Iss. 1
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top